Publication | Closed Access

Synthesis and biological evaluation of benzothiazol-based 1,3,4-oxadiazole derivatives as amyloid β-targeted compounds against Alzheimer’s disease

Amyloid β-Targeted CompoundsBenzothiazol-based 1,3,4-Oxadiazole DerivativesAlzheimer's DiseaseDerivativesBiochemistryMedicinePharmacological AgentOrganic ChemistryAlzheimer ’PharmacologyPharmaceutical Chemistry